LA JOLLA PHARMACEUTICAL CO Deferred Tax Assets, Net of Valuation Allowance
LA JOLLA PHARMACEUTICAL CO had Deferred Tax Assets, Net of Valuation Allowance of $21.19 million as of 2012-12-31, per its 10-K filed 2013-04-01.
Discontinued › Notes › Income Taxes › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsNet · last filed 2013-04-01
- 2012-12-31: Deferred Tax Assets, Net of Valuation Allowance $21.19M.
- 2011-12-31: Deferred Tax Assets, Net of Valuation Allowance $11.16M.
| Period end | Deferred Tax Assets, Net of Valuation Allowance |
|---|---|
| 2012-12-31 | $21.19M 10-K · filed 2013-04-01 |
| 2011-12-31 | $11.16M 10-K · filed 2013-04-01 |